FOI release

Adverse effects of Roaccutane

Case reference FOI2026/01076

Received 16 September 2026

Published 15 October 2026

Request

We hereby request any information you hold and can provide regarding the adverse effects of Roaccutane, in particular in relation to mental health, including depression, mood and suicide, including reports regarding same from 2016 onwards.

Response

See attached

Documents

• FOI2026_01076 (redacted).pdf (803.9 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.